Mode
Text Size
Log in / Sign up

Patient Questions

Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.

Gastroenterology

Is pathologic complete response a good predictor of survival for esophageal adenocarcinoma?

Yes, for esophageal adenocarcinoma, achieving a pathologic complete response after neoadjuvant therapy is strongly linked to better survival, especially in certain subgroups.

Nephrology

What stage of fibrosis can be treated in the idebenone trial?

The idebenone trial specifically targets patients with non-alcoholic steatohepatitis who have stage 1, 2, or 3 fibrosis.

Gastroenterology

Does neoadjuvant chemoradiation improve resection rates for esophageal adenocarcinoma patients?

For esophageal adenocarcinoma, neoadjuvant chemoradiation does not improve overall resection rates but does increase R0 (margin-negative) resection rates compared to chemotherapy…

Gastroenterology

How does single-nucleus RNA sequencing apply to fibrosis research?

Single-nucleus RNA sequencing helps researchers map specific cell types and gene networks that drive fibrosis in the liver and kidneys, revealing how healthy repair fails and how…

Gastroenterology

Are there new immunomodulation strategies to treat liver fibrosis?

Yes, new immunomodulation strategies for liver fibrosis focus on reprogramming macrophages, targeting specific immune subsets, and using metabolic therapies like GLP-1 analogues…

Dermatology

How does bimekizumab compare to placebo for treating moderate to severe chronic plaque psoriasis?

Bimekizumab is significantly more effective than placebo for clearing skin in moderate to severe chronic plaque psoriasis, with Phase 3 trials showing high response rates at week…

Gastroenterology

Can single-cell RNA sequencing help understand fibrosis in fatty liver disease?

Single-cell RNA sequencing helps map specific immune cells and communication networks that drive fibrosis in fatty liver disease, revealing new targets for treatment.

Gastroenterology

What are the gut microbiome differences between diarrheal and non-diarrheal samples?

Diarrheal gut samples show lower bacterial diversity and higher levels of harmful bacteria like E. coli, while healthy samples have more beneficial bacteria like Faecalibacterium.

Primary Care & Family Medicine

Can Life Story Work help young people with Intellectual Disability build identity?

Life Story Work helps young people with intellectual disability build identity by focusing on their roles, relationships, and values rather than just their diagnosis.

Gastroenterology

Is diarrhea in the last few weeks a predictor of slower reaction times?

Research shows that diarrhea in the last few weeks is linked to slower visual reaction times in young children, likely due to nutrient depletion and immune stress.

Hematology

Can ruxolitinib help CMML patients who also have connective tissue disease?

A specific case report shows that combining azacytidine with ruxolitinib helped a patient with connective tissue disease, CMML, and myelofibrosis by reducing fever, correcting…

Neurology

Are there controversies about diagnosing status epilepticus versus other seizure states?

Diagnosing status epilepticus is controversial because subtle symptoms often mimic other conditions, and the line between a seizure and normal brain activity is not always clear…

Hematology

How does the neutrophil-to-lymphocyte ratio predict survival in metastatic cervical cancer treated with immune therapy?

A lower neutrophil-to-lymphocyte ratio (NLR) before starting immune therapy predicts longer survival and better response rates in metastatic cervical cancer, while a higher ratio…

OB/GYN & Women's Health

Does the neutrophil-to-lymphocyte ratio predict progression-free survival in metastatic cervical cancer patients?

A high neutrophil-to-lymphocyte ratio (NLR) before treatment predicts shorter progression-free survival in metastatic cervical cancer patients receiving immunotherapy, while a…

Allergy & Immunology

What immune checkpoint inhibitor is best for survival in metastatic cervical cancer?

Pembrolizumab plus chemotherapy is the best-supported immune checkpoint inhibitor for improving overall survival in metastatic cervical cancer, especially in PD-L1 positive…

Hematology

What happens if a CMML patient is first diagnosed with ITP?

CMML can be misdiagnosed as ITP when thrombocytopenia is the first symptom; immunosuppressive therapy may temporarily raise platelets, but the underlying CMML progresses…

Pulmonology & Critical Care

Do gepants help reduce monthly migraines in patients with episodic migraine?

Oral gepants like rimegepant and atogepant reduce monthly migraine days in episodic migraine, with rimegepant showing sustained benefits up to 52 weeks in trials.

Neurology

Does resting-state fMRI show lower brain entropy in episodic migraine than in healthy people?

Yes, resting-state fMRI studies show that people with episodic migraine have lower brain entropy in key brain networks compared to healthy people.

Pulmonology & Critical Care

Does intravenous eptinezumab help reduce pain during an ongoing episodic migraine attack?

Intravenous eptinezumab can reduce pain and symptoms during an ongoing episodic migraine attack, with improvements seen within the first 10 to 20 minutes of infusion.

Neurology

What is the success rate for microvascular decompression in multiple sclerosis trigeminal neuralgia?

Microvascular decompression (MVD) shows a 30.2% long-term success rate for pain relief in multiple sclerosis-related trigeminal neuralgia, though some single-center studies…

Neurology

Are there specific prediction models for trigeminal neuralgia recurrence in 4,291 patients?

Yes, a 2025 meta-analysis analyzed 4,291 patients to create prediction models for trigeminal neuralgia recurrence, finding an average accuracy of 0.86.

Neurology

How effective is percutaneous balloon compression for multiple sclerosis trigeminal neuralgia patients?

Percutaneous balloon compression offers strong initial pain relief for multiple sclerosis-related trigeminal neuralgia, but pain often returns within a year, and the procedure…

Oncology

What new treatments for autoimmune diseases are emerging from cancer research?

Cancer research is producing new treatments for autoimmune diseases by adapting cell therapies like CAR-T cells and targeting shared inflammatory pathways such as IRAK4 and…

Hematology

How might hematopoietic stem cell therapies impact patients with autoimmune diseases?

Hematopoietic stem cell (HSC) therapies can reset the immune system to stop autoimmune attacks, though they carry risks like infection and require careful nutrition and monitoring.

How this works

We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.

This is not medical advice. Always speak with your own doctor before making decisions about your health.